Deleterious influence of pyrazinamide on the outcome of patients with fulminant or subfulminant liver failure during antituberculous treatment including isoniazid

Hepatology

Volumn 21, Issue 4, 1995, Pages 929-932

  Durand, François ^a   Bernuau, Jacques ^a   Pessayre, Dominique ^a   Samuel, Didier ^b   Belaiche, Jacques ^c   Degott, Claude ^a   Bismuth, Henri ^b   Belghiti, Jacques ^a   Erlinger, Serge ^a   Rueff, Bernard ^a   Benhamou, Jean Pierre ^a  

^a BEAUJON HOSPITAL   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATIC COMA; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER FAILURE; LIVER TOXICITY; LIVER TRANSPLANTATION; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL; TUBERCULOSIS;

ADOLESCENT; ADULT; AGED; DRUG THERAPY, COMBINATION; FEMALE; HEPATIC ENCEPHALOPATHY; HUMAN; ISONIAZID; LIVER TRANSPLANTATION; MALE; MIDDLE AGE; PYRAZINAMIDE; RIFAMPIN; SURVIVAL RATE;

EID: 0028968246     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1016/0270-9139(95)90236-8     Document Type: Article

References (18)

1. The new tuberculosis
2. Treating tuberculosis: what drugs for how long?
3. Fulminant and subfulminant liver failure
4. Isoniazid-rifampin fulminant hepatitis: a possible consequence of the enhancement of hepatotoxicity by enzyme induction
5. Toxic hepatitis with isoniazid and rifampin: a meta-analysis
6. Hépatite fulminante au pyrazinamide [Letter]
7. Emergency liver transplantation for fulminant hepatitis
8. Criteria for emergency liver transplantation in patients with acute viral hepatitis and factor V (FV) below 50% of normal: a prospective study
9. Treatment of tuberculosis and tuberculosis infection in adults and children
10. Early indicators of prognosis in fulminant hepatic failure
11. Induction and inhibition of drug metabolizing enzymes by rifampicin
12. Isoniazid hepatotoxicity: the relationship between covalent binding and metabolism in vivo
13. Pyrazinamide-induced acute yellow atrophy of the liver
14. Fulminant hepatitis during treatment with rifampicin, pyrazinamide and ethambutol
15. Fatal hepatotoxicity of anti-tubercular chemotherapy [Letter]
16. La toxicité du pyrazinamide dans les traitements antituberculeux